NCT01069003View on ClinicalTrials.gov

EDUCATE: The MEDTRONIC Endeavor Drug Eluting Stenting: Understanding Care, Antiplatelet Agents and Thrombotic Events

PHASE4CompletedINTERVENTIONAL
Enrollment

2,272

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Coronary Artery Disease
Interventions
DRUG

Placebo Arm

Placebo and ASA (75 mg - 325 mg)

DRUG

Thienopyridine Therapy

Prasugrel 5 or 10 mg or Clopidogrel 75 mg plus ASA (75 mg - 325 mg)

DEVICE

Surveillance Arm

Non randomized arm to understand clinical outcomes in a commercial setting

Trial Locations (1)

29621

AnMed Health Medical Center, Anderson

Sponsors

Lead Sponsor

Medtronic Vascular
All Listed Sponsors
lead

Medtronic Vascular

INDUSTRY